Form 4: Acadia CFO Young Acquires 48,445 Shares

Acadia Healthcare's Chief Financial Officer, Todd S. Young, acquired 48,445 shares of common stock as part of a compensation plan, vesting over three years.

Summary

• Todd S. Young, Chief Financial Officer of Acadia Healthcare Company, Inc. (ACHC), acquired 48,445 shares of common stock.
• The transaction date for this acquisition was October 27, 2025.
• The shares were acquired at a price of $0.00, indicating a grant or award rather than a market purchase.
• Following this transaction, Todd S. Young beneficially owns 48,445 shares of common stock.
• The acquired shares will vest over a three-year period, with equal yearly installments beginning on October 27, 2026.
• The transaction was made pursuant to a Rule 10b5-1 plan, a pre-arranged contract for the purchase or sale of equity securities.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive, even as a grant, is generally viewed positively as it aligns management's financial interests with those of shareholders. This is a routine compensation event, not indicative of extraordinary news, hence a moderately positive score.

Positives

• The acquisition of shares by the Chief Financial Officer aligns management's interests with those of shareholders, potentially signaling confidence in the company's long-term performance.
• The use of a Rule 10b5-1 plan demonstrates a pre-planned and transparent approach to executive equity compensation.

Future Outlook

The acquired shares are subject to a three-year vesting schedule, with the first installment vesting on October 27, 2026, indicating a long-term incentive structure for the Chief Financial Officer.

Industry Context

Executive equity compensation, often structured with vesting periods and Rule 10b5-1 plans, is a standard practice across industries, including healthcare, to incentivize long-term performance and align executive interests with shareholder value. This filing reflects a routine aspect of executive compensation within the healthcare sector.

Comparison to Industry Standards

• The grant of restricted stock or similar equity awards with a multi-year vesting schedule is a common practice for executive compensation in publicly traded companies, consistent with industry standards for aligning management incentives with long-term shareholder value.
• The use of a Rule 10b5-1 plan for such transactions is also a standard corporate governance practice, providing an affirmative defense against insider trading allegations by pre-scheduling trades.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of the Chief Financial Officer's financial interests with shareholder value due to direct equity ownership.
• Employees: May signal stability and confidence in the company's future, potentially boosting morale.

Next Steps

• The acquired shares will vest in equal yearly installments over a three-year period, commencing on October 27, 2026.

Key Dates

Recommendation

This Form 4 filing reports a routine equity compensation grant to a key executive, which is a standard practice to align management interests with shareholders. It does not contain new financial performance data, strategic shifts, or other material information that would typically warrant a change in an investment recommendation. Therefore, an investor would likely maintain their current position based solely on this filing.

Keywords

ACHC, Acadia Healthcare, Todd S. Young, CFO, Insider Transaction, Form 4, Equity Compensation, Restricted Stock, 10b5-1 Plan